The Kroger Company will settle its opioids lawsuit in West Virginia by paying $68 million. In this case, the retailer was accused of contributing to the oversupply of the said drugs that are legally available with a prescription.
The state of West Virginia also alleged that Kroger failed to control the sale of opioids which is a type of drug that includes heroin which is illegal. Synthetic opioids like fentanyl and pain relievers are being sold to patients with prescriptions so they can be purchased in leading drug stores.
Patrick Morrisey, the West Virginia Attorney General, confirmed on Thursday, May 3, that Kroger has settled the lawsuit. The Cincinnati, Ohio-headquartered retail chain is the last defendant in the case, which also involves other major drug stores in the United States, including Rite Aid, Walgreens, CVS, and Walmart.
“Although the hundreds of millions of dollars we secured from these companies will not bring back the lives lost from the opioid menace, our hope is that the money would provide significant help to those affected the most by this crisis in the state,” the attorney general said in a statement.
On the other hand, Kroger’s spokesman also commented that while the company “continues to believe that the allegations made against Kroger in this and other opioid lawsuits are without merit, we have decided that a settlement is the best path forward to resolve this litigation.”
At any rate, CNN Business reported that despite the hefty payment to resolve the opioid suit, the financial impact on Kroger will remain minimal. This is because it reported $4.1 billion in earnings in 2022.
Walgreens also settled with the state of West Virginia in January this year and paid $83 million, while CVS and Walmart resolved the suit with settlements of $82.5 million and $65 million, respectively, in late 2022. In the case of Rite Aid, it paid up to $30 million in August of last year.
Photo by: Mike Kalasnik/Flickr (CC BY-SA 2.0)


Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
US Signals More Joint Yen Intervention With Japan if Currency Volatility Continues
Gold Prices Rise as Trump Delays Iran Strike, Oil Slumps
US Stock Futures Rise as Trump’s Iran Talks Boost Market Sentiment Ahead of Key Earnings
KOSPI Drops Nearly 5% as Samsung, SK Hynix Lead AI Stock Selloff
South Korea Exports Surge 62.8% in July on AI Chip Demand
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets
U.S. Treasury Joins Japan in Yen Intervention as Currency Nears 40-Year Lows
US Stock Futures Rise as Trump Signals Iran Talks, Markets Await SpaceX Earnings and Jobs Data
UK Stock Market May Outperform if AI Bubble Bursts, Capital Economics Says
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners 



